Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Colorcon
McKesson
Boehringer Ingelheim
Moodys

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Xanodyne Pharm Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for XANODYNE PHARM, and what generic and branded alternatives to XANODYNE PHARM drugs are available?

XANODYNE PHARM has nine approved drugs.



Summary for Xanodyne Pharm
US Patents:0
Tradenames:10
Ingredients:7
NDAs:9
Patent Litigation for Xanodyne Pharm: See patent lawsuits for Xanodyne Pharm

Drugs and US Patents for Xanodyne Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xanodyne Pharm LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 018459-001 Jan 30, 1986 DISCN No No   Start Trial   Start Trial
Xanodyne Pharm DARVOCET-N 50 acetaminophen; propoxyphene napsylate TABLET;ORAL 017122-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Xanodyne Pharm DARVON COMPOUND aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 010996-006 Mar 8, 1983 DISCN No No   Start Trial   Start Trial
Xanodyne Pharm LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 071104-001 Mar 4, 1987 DISCN No No   Start Trial   Start Trial
Xanodyne Pharms Inc ORAMORPH SR morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019977-001 Aug 15, 1991 DISCN No No   Start Trial   Start Trial
Xanodyne Pharm DARVOCET-N 100 acetaminophen; propoxyphene napsylate TABLET;ORAL 017122-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Xanodyne Pharms Inc ORAMORPH SR morphine sulfate TABLET, EXTENDED RELEASE;ORAL 019977-002 Aug 15, 1991 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
McKesson
Boehringer Ingelheim
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.